High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder - No Study Results Posted

High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder (HDQ)

This study is ongoing, but not recruiting participants.

Study NCT00297947 Information provided by Manhattan Psychiatric Center

First Received: February 27, 2006 Last Updated: July 28, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2012
Primary Completion Date:	October 2009 (Final data collection date for primary outcome measure)

No publications provided by Manhattan Psychiatric Center

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Lindenmayer JP, Citrome L, Khan A, Kaushik S, Kaushik S. A randomized, double-blind, parallel-group, fixed-dose, clinical trial of quetiapine at 600 versus 1200 mg/d for patients with treatment-resistant schizophrenia or schizoaffective disorder. J Clin Psychopharmacol. 2011 Apr;31(2):160-8.